Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. j. med. biol. res ; 47(10): 911-916, 10/2014. tab, graf
Artigo em Inglês | LILACS | ID: lil-722166

RESUMO

Anastomotic dehiscence is the most severe complication of colorectal surgery. Metalloproteinases (MMPs) and interleukins (ILs) can be used to analyze the healing process of anastomosis. To evaluate the effects of bromopride on MMP and cytokine gene expression in left colonic anastomoses in rats with or without induced abdominal sepsis, 80 rats were divided into two groups for euthanasia on the third or seventh postoperative day (POD). They were then divided into subgroups of 20 rats for sepsis induction or not, and then into subgroups of 10 rats for administration of bromopride or saline. Left colonic anastomosis was performed and abdominal sepsis was induced by cecal ligation and puncture. A colonic segment containing the anastomosis was removed for analysis of gene expression of MMP-1α, MMP-8, MMP-13, IL-β, IL-6, IL-10, tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ). On the third POD, bromopride was associated with increased MMP-1α, MMP-13, IL-6, IFN-γ, and IL-10 gene expression. On the seventh POD, all MMP transcripts became negatively modulated and all IL transcripts became positively modulated. In the presence of sepsis, bromopride administration increased MMP-8 and IFN-γ gene expression and decreased MMP-1, TNF-α, IL-6, and IL-10 gene expression on the third POD. On the seventh POD, we observed increased expression of MMP-13 and all cytokines, except for TNF-α. In conclusion, bromopride interferes with MMP and IL gene expression during anastomotic healing. Further studies are needed to correlate these changes with the healing process.


Assuntos
Animais , Masculino , Antieméticos/farmacologia , Colo Descendente/cirurgia , Expressão Gênica/efeitos dos fármacos , Interleucinas/metabolismo , Metaloproteinases da Matriz/metabolismo , Metoclopramida/análogos & derivados , Anastomose Cirúrgica , Ceco/cirurgia , Interferon gama/análise , Interleucina-1beta/análise , /análise , /análise , Interleucinas/genética , Ligadura , Metaloproteinase 1 da Matriz/análise , /análise , /análise , Metaloproteinases da Matriz/genética , Metoclopramida/farmacologia , Punções , Ratos Wistar , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Sepse/etiologia , Fator de Necrose Tumoral alfa/análise , Cicatrização/efeitos dos fármacos
2.
Artigo em Português | LILACS-Express | LILACS, VETINDEX | ID: biblio-1489524

RESUMO

O termo vitamina, originária da expressão vital amin, foi utilizado para se referir as certas substâncias alimentares imprescindíveis à saúde. Albert von Szent-Gyorgyi (1928) descobriu e isolou o fator antiescorbútico em vários alimentos, denominando-o vitamina C ou ácido ascórbico (AA). Foi popularizado (1970) por Linus Pauling (Nobel), que recomendava megadoses para combater doenças comuns, degenerativas e na prevenção do câncer.

3.
GED gastroenterol. endosc. dig ; 21(3): 117-122, maio-jun. 2002. tab
Artigo em Inglês | LILACS | ID: lil-334765

RESUMO

Aim: Tocompare four anti-H. pylori regimes using omeprazole and azithromycin associated to different antimicrobials in peptic ulcer H. pylori positive patients. Patients and methodos: afterinformed consent, 136 endoscopically proven peptic ulcer patients(74 male, 62 female) were randomly assigned to one of thefollowing therapy groups: Group 1: Om 20mg mane for 7 ays + Az 500mgmane for 3 days + tinidazole (Ti) 500mg bid for 7 ays. Group 2: Om 20 mg mane for 7 days + Az 500mane for 3 days + amoxycilin (Am) 500mg tid for 7 days. Group 3 Om 20 mg mane for 7 days + Az 500mg mane for 3 days + furazolidone (F) 200 mg tid for 7 days. Group 4: Om 20 mg mane for 7 days +Az 500mg mane for 3 days + colloidal bismuth subcitrate (CBS) 120 mg tid ( double dose at bedtime) for7 days. The H. Pylori status was assessed before treatment and 94 (63-214) days post treatment using urease test, and 14C-urea breath test. Statistical analysis was performed by Kruskal-Wallis test, chi-square test, Fisher's exact test, and Lancaster & Irvin method. Results: The four groups had similar demographic and clinical characteristics. 120/136 patients completed the study. One patient discontinued treatment due to side effects and 15 were lost to follow-up.32/136 (23.5por cento) hed side effect during treatment, mainly nause. H.pylori eradication in group 3 was statistically different from the other groups ( p=0.000). Group 3 & 4 (statistically non-different) presented significantly more side effects than group 1 and 2 (p=0.002). Conclusion: 1)Om + Associated to F (the cheapest ant- H.Pylori drug) for one week represents an efficient reasonaaable well-tolerates alternatiaaaaaave to H.pylori eradication. 2) Future studies testing F with other macrolides or Az during 7 days can enhance H. Pylori eradication rates


Assuntos
Humanos , Masculino , Feminino , Azitromicina , Furazolidona , Helicobacter pylori , Omeprazol , Fenômenos Químicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA